The ARNA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ARNA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The ARNA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View ARNA Detailed Price Forecast - CNN Money||View ARNA Detailed Summary - Google Finance|
|View ARNA Detailed Summary - Yahoo! Finance||View ARNA Stock Research & Analysis - Zacks.com|
|View ARNA Trends & Analysis - Trade-Ideas||View ARNA Major Holders - Barrons|
|View ARNA Call Transcripts - NASDAQ||View ARNA Breaking News & Analysis - Seeking Alpha|
|View ARNA Annual Report - CompanySpotlight.com||View ARNA OTC Short Report - OTCShortReport.com|
|View ARNA Fundamentals - TradeKing||View ARNA SEC Filings - Bar Chart|
|View Historical Prices for ARNA - The WSJ||View Performance/Total Return for ARNA - Morningstar|
|View the Analyst Estimates for ARNA - MarketWatch||View the Earnings History for ARNA - CNBC|
|View the ARNA Earnings - StockMarketWatch||View ARNA Buy or Sell Recommendations - MacroAxis|
|View the ARNA Bullish Patterns - American Bulls||View ARNA Short Pain Metrics - ShortPainBot.com|
|View ARNA Stock Mentions - StockTwits||View ARNA Stock Mentions - PennyStockTweets|
|View ARNA Stock Mentions - Twitter||View ARNA Investment Forum News - Investor Hub|
|View ARNA Stock Mentions - Yahoo! Message Board||View ARNA Stock Mentions - Seeking Alpha|
|View Insider Transactions for ARNA - SECform4.com||View Insider Transactions for ARNA - Insider Cow|
|View ARNA Major Holdings Summary - CNBC||View Insider Disclosure for ARNA - OTC Markets|
|View Insider Transactions for ARNA - Yahoo! Finance||View Institutional Holdings for ARNA - NASDAQ|
|View ARNA Stock Insight & Charts - FinViz.com||View ARNA Investment Charts - StockCharts.com|
|View ARNA Stock Overview & Charts - BarChart||View ARNA User Generated Charts - Trading View|
Arena Pharmaceuticals to Host R&D Day on October 4 in New York City
Posted on Friday September 21, 2018
SAN DIEGO, Sept. 21, 2018 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (ARNA) today announced that the Company will host an R&D Day to outline key catalysts and new information on the clinical programs for its potentially first- or best-in-class late-stage investigational compounds: etrasimod in inflammatory bowel disease (IBD), ralinepag in pulmonary arterial hypertension (PAH), and olorinab in visceral pain. The Company will also provide updates on its broader portfolio.
Arena Pharmaceuticals to Present at Upcoming Investor Conferences
Posted on Thursday September 20, 2018
A live audio webcast of the presentations will be available under the investor relations section of Arena's website at www.arenapharm.com. A replay of the presentations will be available for 30 days following the events. Arena Pharmaceuticals is focused on delivering novel, transformational medicines with optimized pharmacology and pharmacokinetics to patients globally.
Arena Pharmaceuticals Presents Preclinical Data for Olorinab at International Association for the Study of Pain World Congress
Posted on Monday September 17, 2018
"We are pleased to present data supporting olorinab's antinociceptive effects in visceral sensory pathways," said Preston Klassen, MD, MHS, Executive Vice President, Research and Development and Chief Medical Officer of Arena. "Through its full-agonism and selectivity, we believe olorinab may provide a novel therapeutic approach for sustained relief of visceral pain without psychotropic effects, potentially providing a new treatment option without the risk for dependence or abuse.
Today's Research Reports on Trending Tickers: Arena Pharmaceuticals and Emergent BioSolutions
Posted on Monday September 17, 2018
On Thursday, President Donald Trump instructed aides to carry on with $200 billion tariffs against Chinese goods. “Between high corporate profits, stock buybacks, and muted interest rates, there’s still an underlying bid to the market no matter how you slice it. Arena Pharmaceuticals' stock jumped 3.33% Friday, to close the day at $42.18.